key: cord-0995002-xyyiq3ci authors: Ondruschka, Benjamin; Heinrich, Fabian; Lindenmeyer, Maja; Edler, Carolin; Möbius, Dustin; Czogalla, Jan; Heinemann, Axel; Braun, Fabian; Aepfelbacher, Martin; Lütgehetmann, Marc; Huber, Tobias B. title: Multiorgan tropism of SARS-CoV-2 lineage B.1.1.7 date: 2021-09-06 journal: Int J Legal Med DOI: 10.1007/s00414-021-02691-z sha: 543ecf7367fa24198ef5e736202559fdd1aa773c doc_id: 995002 cord_uid: xyyiq3ci Due to the development of novel functionalities, distinct SARS-CoV-2 variants such as B.1.1.7 fuel the current pandemic. B.1.1.7 is not only more transmissible, but may also cause an increased mortality compared to previous SARS-CoV-2 variants. Human tissue analysis of the SARS-CoV-2 lineage B.1.1.7 is urgently needed, and we here present autopsy data from 7 consecutive SARS-CoV-2 B.1.1.7 cases. The initial RT-qPCR analyses from nasopharyngeal swabs taken post mortem included typing assays for B.1.1.7. We quantitated SARS-CoV-2 B.1.1.7 viral load in autopsy tissue of multiple organs. Highest levels of SARS-CoV-2 B.1.1.7 copies normalized to ß-globin were detected in the respiratory system (lung and pharynx), followed by the liver and heart. Importantly, SARS-CoV-2 lineage B.1.1.7 was found in 100% of cases in the lungs and in 85.7% in pharynx tissue. Detection also in the kidney and brain highlighting a pronounced organ tropism. Comparison of the given results to a former cohort of SARS-CoV-2 deaths during the first wave in spring 2020 showed resembling organ tropism. Our results indicate that also SARS-CoV-2 B.1.1.7 has a relevant organ tropism beyond the respiratory tract. We speculate that B.1.1.7 spike protein’s affinity to human ACE2 facilitates transmission, organ tropism, and ultimately morbidity and mortality. Further studies and larger cohorts are obligatory to proof this link. Due to the development of novel functionalities, distinct SARS-CoV-2 variants such as B.1.1.7 fuel the current pandemic. SARS-CoV-2 lineage B.1.1.7 was first identified in the UK and spread in multiple regions worldwide [1] . B.1.1.7 is not only more transmissible, but may also cause an increased mortality compared to previous SARS-CoV-2 variants [2] . We have previously reported a multiorgan tropism of the initial SARS-CoV-2 lineage [3, 4] that can also associate with organ outcome [5] . Organ tropism thereby correlated with the presence of comorbidities including chronic kidney disease and diabetes [5] . The first case report on autopsy results of a B.1.1.7 fatality was published recently in Int J Legal Med [6] . Human tissue analysis of the SARS-CoV-2 lineage B.1.1.7 is urgently needed, and we here present autopsy data from 7 consecutive SARS-CoV-2 B.1.1.7 cases (clinical data in Table 1 ). These individuals died out-of-hospital (n = 3) and in-hospital (n = 4). The cohort was of high age (median 75 years, interquartile range 52-78 years) with a sex ratio of 4:3 (male:female). The initial RT-qPCR analyses from nasopharyngeal swabs taken post mortem included typing assays for B.1.1.7 in the form of N501Y and del HV69//70 as recently established [7] in combination with screening for E484K and P681H (TIB Molbiol, Berlin, Germany). All outof-hospital deceased were first tested positive post mortem. Full autopsies were done in all cases following guidelines on the handling of COVID-19 deaths [8] . Organ samples were processed and analyzed for the E gene of SARS-CoV-2. We quantitated SARS-CoV-2 B.1.1.7 viral load in autopsy tissue of multiple organs. Highest levels of SARS-CoV-2 B.1.1.7 copies normalized to ß-globin were detected in the respiratory system (lung and pharynx), followed by the liver and heart (Fig. 1) . Importantly, SARS-CoV-2 lineage B.1.1.7 was found in 100% of cases in the lungs (7/7), in 85.7% in pharynx tissue (6/7), in 57.1% in the liver and heart (4/7 each), and in 42.9% in the kidney and brain (3/7) highlighting a pronounced organ tropism (Fig. 1) . Comparison of the given results to a former cohort of 27 SARS-CoV-2 deaths during the first wave in spring 2020 [3] showed resembling organ tropism (Fig. 1) . Our results indicate that also SARS-CoV-2 B.1.1.7 has a relevant organ tropism beyond the respiratory tract. We speculate that B.1.1.7 spike protein's affinity to human ACE2 facilitates transmission, organ tropism, and ultimately morbidity and mortality. Further studies and larger cohorts are obligatory to proof this link and our forensic discipline is again one of the key players for this task. Informed consent Informed consent was obtained from the relatives of the deceased. We want to offer condolences to the families and friends of all COVID-19 deceased. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/. 1 f 70 6 OH 4 1 2 1 0 0 0 2 m 76 2 NW 4 0 3 0 0 0 0 3 f 78 6 OH 4 1 2 0 0 1 0 4 m 85 4 ICU 4 0 3 0 0 0 1 5 m 45 2 ICU 2 0 1 0 0 0 1 6 m 75 12 ICU 5 1 2 1 0 1 0 7 f 52 8 OH 3 [3] were opposed in grey dots as SARS-CoV-2 original lineage values and were also normalized to ß-globin The variant gambit: COVID-19's next move Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7 Multiorgan and renal tropism of SARS-CoV-2 Dying with SARS-CoV-2 infection -an autopsy study of the first consecutive SARS-CoV-2 renal tropism associates with acute kidney injury Dying of VOC-202012/01 -multimodal investigations in a death case of the SARS-CoV-2 variant Evaluation of a fully automated high-throughput SARS-CoV-2 multiplex qPCR assay with buildin screening functionality to DelHV69/70-and N501Y variants such as B.1.1.7 Autopsy in suspected COVID-19 cases Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations